Terug
Dagbereik
€ 154,49
€ 159,35
52-Weeksbereik
€ 91,86
€ 228,88
Volume
602.544
50D / 200D Gem.
€ 186,54
/
€ 173,06
Vorige Slotkoers
€ 153,60
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -53,9 | 0,4 |
| P/B | 2,5 | 2,9 |
| ROE % | -4,4 | 3,8 |
| Net Margin % | -3,6 | 3,9 |
| Rev Growth 5Y % | 3,2 | 10,0 |
| D/E | 1,0 | 0,2 |
Koersdoel Analisten
Hold
€ 202,17
+28.0%
Low: € 175,00
High: € 260,00
Forward K/W
14,3
Forward WPA
€ 11,07
WPA Groei (sch.)
+0,0%
Omzet Sch.
4 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 15,50
€ 15,36 – € 15,63
|
4,6 B | 1 |
| FY2029 |
€ 14,07
€ 13,94 – € 14,19
|
4,6 B | 1 |
| FY2028 |
€ 13,18
€ 13,07 – € 13,30
|
4,3 B | 1 |
Belangrijkste Punten
Revenue grew 3,20% annually over 5 years — modest growth
Earnings declined -1501,75% over the past year
Generating 518,49M in free cash flow
PEG of 0,05 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,05%
Capital efficient — spends only 5,46% of revenue on capex
Groei
Revenue Growth (5Y)
3,20%
Revenue (1Y)-0,85%
Earnings (1Y)-1501,75%
FCF Growth (3Y)19,13%
Kwaliteit
Return on Equity
-4,36%
ROIC6,11%
Net Margin-3,59%
Op. Margin12,65%
Veiligheid
Debt / Equity
0,97
Current Ratio1,29
Interest Coverage4,74
Waardering
P/E Ratio
-53,89
P/B Ratio2,46
EV/EBITDA20,93
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,85% | Revenue Growth (3Y) | -1,39% |
| Earnings Growth (1Y) | -1501,75% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3,20% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,02B | Net Income (TTM) | -144,34M |
| ROE | -4,36% | ROA | -2,02% |
| Gross Margin | 30,52% | Operating Margin | 12,65% |
| Net Margin | -3,59% | Free Cash Flow (TTM) | 518,49M |
| ROIC | 6,11% | FCF Growth (3Y) | 19,13% |
| Safety | |||
| Debt / Equity | 0,97 | Current Ratio | 1,29 |
| Interest Coverage | 4,74 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -53,89 | P/B Ratio | 2,46 |
| P/S Ratio | 1,94 | PEG Ratio | 0,05 |
| EV/EBITDA | 20,93 | Dividend Yield | 0,00% |
| Market Cap | 7,78B | Enterprise Value | 10,63B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,02B | 4,05B | 4,13B | 3,98B | 3,54B |
| Net Income | -144,34M | 10,30M | 474,62M | 486,23M | 390,98M |
| EPS (Diluted) | -2,91 | 0,20 | 9,22 | 9,48 | 7,60 |
| Gross Profit | 1,23B | 1,33B | 1,50B | 1,46B | 1,33B |
| Operating Income | 507,84M | 227,35M | 617,26M | 650,98M | 589,86M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 7,14B | 7,53B | 8,20B | 7,60B | 7,02B |
| Total Liabilities | 3,92B | 4,02B | 4,54B | 4,58B | 4,43B |
| Shareholders' Equity | 3,16B | 3,46B | 3,60B | 2,98B | 2,53B |
| Total Debt | 3,07B | 2,72B | 3,07B | 3,10B | 3,21B |
| Cash & Equivalents | 213,77M | 194,61M | 276,77M | 233,91M | 245,24M |
| Current Assets | 1,45B | 1,40B | 1,61B | 1,44B | 1,27B |
| Current Liabilities | 1,12B | 994,10M | 1,06B | 1,09B | 1,03B |